Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2022

Start date
28 Nov 2022
End date
29 Nov 2022
Virtual, GMT +8
Application deadline
23 Aug 2022 at 23:59 CEST

Please kindly note that the virtual course programme timings are to be considered GMT+8 (Singapore Local Time)

Learning Objectives 

  • Understanding the function and biology of KRAS in normal and malignant cells
  • Gaining insights in the spectrum of KRAS molecular aberrations, platforms and strategies for molecular testing
  • In depth discussion of emerging therapeutic strategies and clinical research in KRAS mutated NSCLC
  • Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of KRAS G12C inhibition and beyond

Download the programme 

Apply now! 

How to apply

Application is via online form. During the application process you will be required to upload the following:

  • Your CV including a list of your publications

Application deadline

Application for the virtual course will close on 23 August 2022

Who can apply?

While this online course is primarily aimed at experienced oncologists resident in Asia, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.


The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.


  • Myung-Ju Ahn, Republic of Korea
  • Federica Di Nicolantonio, Italy

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.